Peer-influenced content. Sources you trust. No registration required. This is HCN.
Infectious Disease Advisor
“We believe that the commercial launch of Zelsuvmi marks a significant advancement for patients with molluscum and their caregivers, who previously lacked an at-home treatment option.”
Dermatology July 31st 2025
Epoch Health
Physicians report systematic shift from respiratory-predominant to throat-predominant symptom presentation, requiring updated clinical assessment protocols.
Emergency Medicine June 26th 2025
DermNet
Although originally described in children with hepatitis B, vaccination against this virus in most populations means EBV is now the most common association.
Dermatology April 10th 2025
GoodRx for Healthcare Professionals
Antiviral therapy initiated within 48 hours of symptom onset can reduce illness duration by 1-2 days, highlighting the importance of early recognition and intervention in high-risk populations.
Emergency Medicine January 30th 2025
Mayo Clinic Health System
Proper timing of dietary progression and recognition of warning signs remain crucial elements in managing viral gastroenteritis, particularly in vulnerable populations where complications are more common.
Emergency Medicine January 15th 2025
Recent evidence suggests a potential link between pityriasis rosea and various viral infections, including COVID-19, expanding our understanding of this common dermatological condition’s etiology.
Dermatology January 15th 2025